Previous close | 71.00 |
Open | 73.50 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 73.50 - 74.50 |
52-week range | 49.40 - 80.50 |
Volume | |
Avg. volume | 0 |
Market cap | 11.828B |
Beta (5Y monthly) | 1.23 |
PE ratio (TTM) | 64.22 |
EPS (TTM) | 1.16 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | 0.30 (0.40%) |
Ex-dividend date | 10 May 2024 |
1y target est | 549.60 |
Bio-Techne ( NASDAQ:TECH ) Third Quarter 2024 Results Key Financial Results Revenue: US$303.4m (up 3.2% from 3Q 2023...
The S&P 500 is up for the fourth consecutive session. While many stocks have powered the ETF, we have highlighted five that have led the way higher.
Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities Health Care Conference on Tuesday, May 14, 2024, at 2:20 p.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.